Efficacy and safety of artesunate–amodiaquine and artemether–lumefantrine and prevalence of molecular markers associated with resistance, Guinea: an open-label two-arm randomised controlled trial

BACKGROUND: Anti-malarial resistance is a threat to recent gains in malaria control. This study aimed to assess the efficacy and safety of artesunate–amodiaquine (ASAQ) and artemether–lumefantrine (AL) in the management of uncomplicated malaria and to measure the prevalence of molecular markers of r...

Descripción completa

Detalles Bibliográficos
Autores principales: Beavogui, Abdoul Habib, Camara, Alioune, Delamou, Alexandre, Diallo, Mamadou Saliou, Doumbouya, Abdoulaye, Kourouma, Karifa, Bouedouno, Patrice, Guilavogui, Timothée, dos Santos Souza, Samaly, Kelley, Julia, Talundzic, Eldin, Fofana, Aissata, Plucinski, Mateusz M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315541/
https://www.ncbi.nlm.nih.gov/pubmed/32580771
http://dx.doi.org/10.1186/s12936-020-03290-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315541/
https://www.ncbi.nlm.nih.gov/pubmed/32580771
http://dx.doi.org/10.1186/s12936-020-03290-w

Ejemplares similares